Glucovance Tab 1.25mg,250mg 2×15’s

Glucovance Tab 1.25mg,250mg 2×15’s

Glucovance Tab 1.25mg,250mg 2x15's

Glucovance Tab 1.25mg,250mg 2×15’s

57.00

In stock

57.00


Pack Size: 2X15’s


Composition: Glibenclamide 1.25mg, Metformin 250mg


Pharmaceutical form: Tablet


Brand Name: [button link=”https://www.almishkat.pk/product-category/brand-companies/MERCK-MARKER-PVT-LTD/” color=”purple” newwindow=”yes”] MERCK MARKER PVT LTD[/button]


Availability: In stock


Description

Glucovance Tab 1.25mg,250mg 2×15’s

Glucovance Tab 1.25mg,250mg 2×15’s is used to control blood glucose levels (the amount of sugar in the blood) in adults with type II diabetes mellitus. This type of diabetes is also known as non-insulin dependent diabetes mellitus (NIDDM) or maturity onset diabetes.

 For patients not adequately controlled on either glyburide (or another sulfonylurea) or metformin alone, the recommended starting dose of GLUCOVANCE is 2.5 mg/500 mg or 5 mg/500 mg twice daily with the morning and evening meals.
Glyburide use should be avoided in patients with severe kidney impairment as defined by a GFR of less than 60 mL/min (CKD stage 3 and below). Because 50 percent of the glyburide is excreted by the kidneysthe drug can build up in people with CKD, causing low blood sugar levels.

GLUCOVANCE is available for oral administration in tablets containing 1.25 mg glyburide with 250 mg metformin hydrochloride, 2.5 mg glyburide with 500 mg metformin hydrochloride, and 5 mg glyburide with 500 mg metformin hydrochloride. In addition, each tablet contains the following inactive ingredients: microcrystalline cellulose, povidone, croscarmellose sodium, and magnesium stearate. The tablets are film coated, which provides color differentiation.

Uses

Glucovance is used to control blood glucose levels (the amount of sugar in the blood) in adults with type II diabetes mellitus. This type of diabetes is also known as non-insulin dependent diabetes mellitus (NIDDM) or maturity onset diabetes.

Side Effects

In double-blind clinical trials involving GLUCOVANCE as initial therapy or as second-line therapy, a total of 642 patients received GLUCOVANCE, 312 received metformin therapy, 324 received glyburide therapy, and 161 received placebo. The percent of patients reporting events and types of adverse events reported in clinical trials of GLUCOVANCE (all strengths) as initial therapy and second-line therapy are listed in Table 6.

When Not To Use

Glucovance (Glyburide and Metformin) may treat, side effects, dosage, drug interactions … GLUCOVANCE 5 mg/500 mg should not be used as initial therapy due to an … GLUCOVANCE 2.5 mg/500 mg tablet is a pale orange, capsule-shaped.

Reviews

There are no reviews yet.


Be the first to review “Glucovance Tab 1.25mg,250mg 2×15’s”